Patents by Inventor Thomas Benedict Bryan

Thomas Benedict Bryan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220117924
    Abstract: The invention relates to compositions that include non-toxic, non-bonded amino acids, individually or in combination, with or without glycerol and other ingredients, used to prevent and treat disease caused by biofilm producing bacteria, fungi, hybrid, or protozoan microorganisms in animals including humans, and to generally prevent reduce, or destroy biofilms by inhibition of formation and in destruction of said biofilms in various other applications.
    Type: Application
    Filed: December 29, 2021
    Publication date: April 21, 2022
    Inventor: Thomas Benedict Bryan
  • Publication number: 20180153840
    Abstract: The invention relates to compositions that include non-toxic, non-bonded amino acids, individually or in combination, with or without glycerol and other ingredients, used to prevent and treat disease caused by biofilm producing bacteria, fungi, hybrid, or protozoan microorganisms in animals including humans, and to generally prevent reduce, or destroy biofilms by inhibition of formation and in destruction of said biofilms in various other applications.
    Type: Application
    Filed: December 29, 2017
    Publication date: June 7, 2018
    Inventor: Thomas Benedict Bryan
  • Publication number: 20170042851
    Abstract: Disclosed is a method comprising the administration of a 3% amino acid and 3% glycerin solution for the use of prevention and disruption of bacterial biofilms. Also disclosed is method comprising the administration of L-cysteine 0.4 g per 100 ml for the prevention and destruction of fungal biofilms.
    Type: Application
    Filed: October 31, 2016
    Publication date: February 16, 2017
    Applicant: The Regents of the University of California
    Inventors: Thomas Benedict Bryan, Clarissa J. Nobile
  • Patent number: 9480669
    Abstract: Disclosed is a method comprising the administration of a 3% amino acid and 3% glycerin solution for the use of prevention and disruption of bacterial biofilms. Also disclosed is method comprising the administration of L-cysteine 0.4 g per 100 ml for the prevention and destruction of fungal biofilms.
    Type: Grant
    Filed: January 6, 2015
    Date of Patent: November 1, 2016
    Assignee: The Regents of The University of California
    Inventors: Thomas Benedict Bryan, Clarissa J. Nobile
  • Publication number: 20150126571
    Abstract: Disclosed is a method comprising the administration of a 3% amino acid and 3% glycerin solution for the use of prevention and disruption of bacterial biofilms. Also disclosed is method comprising the administration of L-cysteine 0.4 g per 100 ml for the prevention and destruction of fungal biofilms.
    Type: Application
    Filed: January 6, 2015
    Publication date: May 7, 2015
    Inventor: THOMAS BENEDICT BRYAN
  • Publication number: 20130123319
    Abstract: 3% Glycerin plus 3% amino acids intravenously used for nutritional purposes produces a rapid remission of an acute exacerbation in Behcet's Disease. External manifestations such as oral, vulva, penile and skin lesions rapidly heal when Glycerin is added to the amino acids. While the disease process in Behcet's Disease is likely improved by amino acids alone, the robustness of the healing of open lesions and the overall well-being of the patient in acute exacerbations is greatly enhanced by the addition of 3% Glycerin to the IV fluid. IV 3% Glycerin and 3% Amino Acids also produced remissions in Myasthenia Gravis, Guillain-Barre Disease, and Chronic Inflammatory Demyelinating Polyneuropathy. 3% Glycerin with amino acids could cause healing in many autoimmune diseases and can help external and internal lesions to heal. Glycerin also prevents bacteria from forming a biofilm which in most infections is necessary for the bacteria to become pathologic.
    Type: Application
    Filed: November 15, 2011
    Publication date: May 16, 2013
    Inventor: Thomas Benedict Bryan